Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome (Q73873107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

J G Hanly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S A Smith

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

537-543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844535%20AND%20SRC:MED&resulttype=core&format=json

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

7 November 2019

cites work

1 reference

12 December 2020

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

12 December 2020

Platelet binding properties of monoclonal lupus autoantibodies produced by human hybridomas.

1 reference

12 December 2020

Anticardiolipin response in acute infections

1 reference

12 December 2020

Immunological specificity and mechanism of action of IgG lupus anticoagulants

1 reference

12 December 2020

Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies.

1 reference

12 December 2020

Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders

1 reference

12 December 2020

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

1 reference

12 December 2020

Purification of antiphospholipid antibodies using a new affinity method

1 reference

12 December 2020

Primary antiphospholipid syndrome

1 reference

12 December 2020

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

12 December 2020

The "primary" antiphospholipid syndrome: major clinical and serological features.

1 reference

12 December 2020

Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system

1 reference

12 December 2020

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

12 December 2020

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

12 December 2020

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

12 December 2020

Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin

1 reference

12 December 2020

Immunology and Clinical Importance of Antiphospholipid Antibodies

1 reference

12 December 2020

Annexins: calcium-binding proteins of multi-functional importance?

1 reference

12 December 2020

Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

1 reference

12 December 2020

Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells

1 reference

12 December 2020

Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction

1 reference

12 December 2020

Clustering of lipid-bound annexin V may explain its anticoagulant effect

1 reference

12 December 2020

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

1 reference

12 December 2020

Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation

1 reference

12 December 2020

Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies

1 reference

12 December 2020

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

1 reference

12 December 2020

Antiphospholipid antibodies and venous thromboembolism

1 reference

12 December 2020

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

1 reference

12 December 2020

The antiphospholipid-protein syndrome

1 reference

12 December 2020

The lupus anticoagulant/antiphospholipid syndrome

1 reference

12 December 2020

Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays.

1 reference

12 December 2020

Immunology of the antiphospholipid antibody syndrome

1 reference

12 December 2020

Deep venous thrombosis and lupus anticoagulant. A case-control study

1 reference

12 December 2020

Beta 2-glycoprotein I and anticardiolipin antibody binding to resting and activated cultured human endothelial cells

1 reference

12 December 2020

Antiphospholipid antibodies and the antiphospholipid antibody syndrome

1 reference

12 December 2020

Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti-β2-Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β2-Glycoprotein I and Induce Endothelial Activation

1 reference

12 December 2020

Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism

1 reference

12 December 2020

Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C

1 reference

12 December 2020

Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon

1 reference

12 December 2020

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus

1 reference

12 December 2020

Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020